Duality Advisers’s Fulgent Genetics FLGT Stock Holding History

Duality Advisers’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-23,993	Closed	-$715K	–	631
2022 Q4	$715K	Buy	+23,993	New	+$859K	0.08%	380

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Duality Advisers's FLGT Position: Q1 2023 in Review

Duality Advisers sold out of Fulgent Genetics (FLGT) in Q1 2023, closing a stake of 23,993 shares — an estimated $715K sold.

Duality Advisers first reported a position in FLGT in Q4 2022 and held it in 1 quarter. The position peaked at $715K in Q4 2022. 215 funds tracked by Wall St. Rank hold FLGT as of Q1 2023.

Duality Advisers reported no remaining Fulgent Genetics position as of Q1 2023 after selling out during the quarter.
Duality Advisers sold 23,993 Fulgent Genetics shares in Q1 2023, an estimated $715K.
Duality Advisers first reported a position in Fulgent Genetics in Q4 2022 and held it in 1 quarter.
Duality Advisers's Fulgent Genetics position peaked at $715K in Q4 2022.
215 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2023.

Based on Duality Advisers's 13F filing for Q1 2023, filed 27 Jun 2023.